research A Case of Extensive Alopecia Areata Following Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine with Favorable Outcome
A woman's hair mostly regrew after hair loss from the COVID-19 vaccine with treatment.
Search
forProducts matching "pfizer"
Tracking 1 products like 313 Loniten (minoxidil) 2.5mg tablets front Loniten (minoxidil) 2.5mg tablets back Loniten (minoxidil) 2.5mg tablets from by companies like oxfordon line pharmacy. View product »Learn
0 / 0 results — no results
Research
5 / 878 resultsresearch Case of De Novo Nail Psoriasis Triggered by the Second Dose of Pfizer-BioNTech BNT162b2 COVID-19 Messenger RNA Vaccine
research Pantolactams as Androgen Receptor Antagonists for the Topical Suppression of Sebum Production
Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.
research Letter in Reply: Alopecia Areata After SARS-CoV-2 Vaccination
A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.
research Synthesis and Biological Evaluation of Amino-Pyridines as Androgen Receptor Antagonists for Stimulating Hair Growth and Reducing Sebum Production
A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.
Community Join
5 / 40 results
community Compunded Oral Minoxidil, As Efficient As Tablet Variants?
The user discusses using compounded oral minoxidil due to the ineffectiveness and inconvenience of topical minoxidil for diffuse thinning. They question the efficacy of compounded minoxidil compared to original tablet forms and express concerns about the importance of excipients and binders.
community Should I start using min if my hair loss is caused by low ferritin / iron deficiency?
A 24-year-old woman experiencing hair loss due to low ferritin and iron deficiency is advised to correct these deficiencies before considering minoxidil. Minoxidil is not recommended for temporary hair loss caused by iron deficiency.
community Prediction: Scube3 is never coming out
Scube3, a potential hair loss treatment, is unlikely to be released because it was given to a startup company, Amplifica, which may go bankrupt and fail to bring the treatment to market. Amplifica is prioritizing other treatments over Scube3, which could lead to financial loss and the end of Scube3's development.
community Oral Minoxidil Study of 60 AGA patients
Oral minoxidil treatment increased hair density and shaft caliber in AGA patients. Side effects included hypertrichosis and lower extremity edema, with younger patients experiencing fewer side effects.
community Started oral minoxidil today
A user started taking oral minoxidil using Rogaine, despite concerns from others about its safety and proper use. They plan to update on their progress.